APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oxaliplatin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oxaliplatin Injection Industry Research Report 2026

Report ID 174021360520 December 2025146 pages

Choose your research edition.

Industry ResearchOxaliplatin Injection Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxaliplatin Injection Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Oxaliplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxaliplatin Injection Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxaliplatin Injection Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Oxaliplatin Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oxaliplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oxaliplatin Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oxaliplatin Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oxaliplatin Injection include Teva, Sun Pharmaceutical, Qilu Pharmaceutical, Nanjing Pharmaceutical Factory, Mylan, Luoxin, Jiangsu Hengrui Medicine, Hainan Jinrui Pharmaceutical and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oxaliplatin Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oxaliplatin Injection Market by Company

Teva

Sun Pharmaceutical

Qilu Pharmaceutical

Nanjing Pharmaceutical Factory

Mylan

Luoxin

Jiangsu Hengrui Medicine

Hainan Jinrui Pharmaceutical

Fresenius Kabi

YRPG

Yakult honsha

Sanofi-Aventis

Lunan Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Jari Pharmaceutical

Hospira(Pfizer)

Hisun Pharmaceutical

Halfsky Pharmacy

Dr Reddy's laboratories

Chiatai Tianqing

Oxaliplatin Injection Segment by Type

Mannitol

Glucose Solution

Lactose Solution

Other

Oxaliplatin Injection Segment by Application

Colorectal Cancer

Ovarian Cancer

Stomach Cancer

Other

Oxaliplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxaliplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxaliplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxaliplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oxaliplatin Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oxaliplatin Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oxaliplatin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oxaliplatin Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oxaliplatin Injection Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Oxaliplatin Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oxaliplatin Injection Revenue of Manufacturers (2021-2026) Table 9. Global Oxaliplatin Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oxaliplatin Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Oxaliplatin Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oxaliplatin Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oxaliplatin Injection, Product Type & Application Table 14. Global Oxaliplatin Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oxaliplatin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Company Information Table 19. Teva Business Overview Table 20. Teva Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Teva Oxaliplatin Injection Product Portfolio Table 22. Teva Recent Developments Table 23. Sun Pharmaceutical Company Information Table 24. Sun Pharmaceutical Business Overview Table 25. Sun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sun Pharmaceutical Oxaliplatin Injection Product Portfolio Table 27. Sun Pharmaceutical Recent Developments Table 28. Qilu Pharmaceutical Company Information Table 29. Qilu Pharmaceutical Business Overview Table 30. Qilu Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Qilu Pharmaceutical Oxaliplatin Injection Product Portfolio Table 32. Qilu Pharmaceutical Recent Developments Table 33. Nanjing Pharmaceutical Factory Company Information Table 34. Nanjing Pharmaceutical Factory Business Overview Table 35. Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Nanjing Pharmaceutical Factory Oxaliplatin Injection Product Portfolio Table 37. Nanjing Pharmaceutical Factory Recent Developments Table 38. Mylan Company Information Table 39. Mylan Business Overview Table 40. Mylan Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Mylan Oxaliplatin Injection Product Portfolio Table 42. Mylan Recent Developments Table 43. Luoxin Company Information Table 44. Luoxin Business Overview Table 45. Luoxin Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Luoxin Oxaliplatin Injection Product Portfolio Table 47. Luoxin Recent Developments Table 48. Jiangsu Hengrui Medicine Company Information Table 49. Jiangsu Hengrui Medicine Business Overview Table 50. Jiangsu Hengrui Medicine Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Jiangsu Hengrui Medicine Oxaliplatin Injection Product Portfolio Table 52. Jiangsu Hengrui Medicine Recent Developments Table 53. Hainan Jinrui Pharmaceutical Company Information Table 54. Hainan Jinrui Pharmaceutical Business Overview Table 55. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Product Portfolio Table 57. Hainan Jinrui Pharmaceutical Recent Developments Table 58. Fresenius Kabi Company Information Table 59. Fresenius Kabi Business Overview Table 60. Fresenius Kabi Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Fresenius Kabi Oxaliplatin Injection Product Portfolio Table 62. Fresenius Kabi Recent Developments Table 63. YRPG Company Information Table 64. YRPG Business Overview Table 65. YRPG Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. YRPG Oxaliplatin Injection Product Portfolio Table 67. YRPG Recent Developments Table 68. Yakult honsha Company Information Table 69. Yakult honsha Business Overview Table 70. Yakult honsha Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Yakult honsha Oxaliplatin Injection Product Portfolio Table 72. Yakult honsha Recent Developments Table 73. Sanofi-Aventis Company Information Table 74. Sanofi-Aventis Business Overview Table 75. Sanofi-Aventis Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sanofi-Aventis Oxaliplatin Injection Product Portfolio Table 77. Sanofi-Aventis Recent Developments Table 78. Lunan Pharmaceutical Company Information Table 79. Lunan Pharmaceutical Business Overview Table 80. Lunan Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Lunan Pharmaceutical Oxaliplatin Injection Product Portfolio Table 82. Lunan Pharmaceutical Recent Developments Table 83. Jiangsu Aosaikang Pharmaceutical Company Information Table 84. Jiangsu Aosaikang Pharmaceutical Business Overview Table 85. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Product Portfolio Table 87. Jiangsu Aosaikang Pharmaceutical Recent Developments Table 88. Jari Pharmaceutical Company Information Table 89. Jari Pharmaceutical Business Overview Table 90. Jari Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Jari Pharmaceutical Oxaliplatin Injection Product Portfolio Table 92. Jari Pharmaceutical Recent Developments Table 93. Hospira(Pfizer) Company Information Table 94. Hospira(Pfizer) Business Overview Table 95. Hospira(Pfizer) Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hospira(Pfizer) Oxaliplatin Injection Product Portfolio Table 97. Hospira(Pfizer) Recent Developments Table 98. Hisun Pharmaceutical Company Information Table 99. Hisun Pharmaceutical Business Overview Table 100. Hisun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hisun Pharmaceutical Oxaliplatin Injection Product Portfolio Table 102. Hisun Pharmaceutical Recent Developments Table 103. Halfsky Pharmacy Company Information Table 104. Halfsky Pharmacy Business Overview Table 105. Halfsky Pharmacy Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Halfsky Pharmacy Oxaliplatin Injection Product Portfolio Table 107. Halfsky Pharmacy Recent Developments Table 108. Dr Reddy's laboratories Company Information Table 109. Dr Reddy's laboratories Business Overview Table 110. Dr Reddy's laboratories Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Dr Reddy's laboratories Oxaliplatin Injection Product Portfolio Table 112. Dr Reddy's laboratories Recent Developments Table 113. Chiatai Tianqing Company Information Table 114. Chiatai Tianqing Business Overview Table 115. Chiatai Tianqing Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Chiatai Tianqing Oxaliplatin Injection Product Portfolio Table 117. Chiatai Tianqing Recent Developments Table 118. Global Oxaliplatin Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Oxaliplatin Injection Sales by Region (2021-2026) & (K Units) Table 120. Global Oxaliplatin Injection Sales Market Share by Region (2021-2026) Table 121. Global Oxaliplatin Injection Sales by Region (2027-2032) & (K Units) Table 122. Global Oxaliplatin Injection Sales Market Share by Region (2027-2032) Table 123. Global Oxaliplatin Injection Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Oxaliplatin Injection Revenue Market Share by Region (2021-2026) Table 125. Global Oxaliplatin Injection Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Oxaliplatin Injection Revenue Market Share by Region (2027-2032) Table 127. North America Oxaliplatin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 129. North America Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 130. North America Oxaliplatin Injection Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Oxaliplatin Injection Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Oxaliplatin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 134. Europe Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 135. Europe Oxaliplatin Injection Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Oxaliplatin Injection Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Oxaliplatin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 139. Asia Pacific Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 140. Asia Pacific Oxaliplatin Injection Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Oxaliplatin Injection Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Oxaliplatin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 144. South America Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 145. South America Oxaliplatin Injection Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Oxaliplatin Injection Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Oxaliplatin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Oxaliplatin Injection Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Oxaliplatin Injection Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Oxaliplatin Injection Sales by Type (2021-2026) & (K Units) Table 153. Global Oxaliplatin Injection Sales by Type (2027-2032) & (K Units) Table 154. Global Oxaliplatin Injection Sales Market Share by Type (2021-2026) Table 155. Global Oxaliplatin Injection Sales Market Share by Type (2027-2032) Table 156. Global Oxaliplatin Injection Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Oxaliplatin Injection Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Oxaliplatin Injection Revenue Market Share by Type (2021-2026) Table 159. Global Oxaliplatin Injection Revenue Market Share by Type (2027-2032) Table 160. Global Oxaliplatin Injection Price by Type (2021-2026) & (US$/Unit) Table 161. Global Oxaliplatin Injection Price by Type (2027-2032) & (US$/Unit) Table 162. Global Oxaliplatin Injection Sales by Application (2021-2026) & (K Units) Table 163. Global Oxaliplatin Injection Sales by Application (2027-2032) & (K Units) Table 164. Global Oxaliplatin Injection Sales Market Share by Application (2021-2026) Table 165. Global Oxaliplatin Injection Sales Market Share by Application (2027-2032) Table 166. Global Oxaliplatin Injection Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Oxaliplatin Injection Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Oxaliplatin Injection Revenue Market Share by Application (2021-2026) Table 169. Global Oxaliplatin Injection Revenue Market Share by Application (2027-2032) Table 170. Global Oxaliplatin Injection Price by Application (2021-2026) & (US$/Unit) Table 171. Global Oxaliplatin Injection Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Oxaliplatin Injection Distributors List Table 175. Oxaliplatin Injection Customers List Table 176. Oxaliplatin Injection Industry Trends Table 177. Oxaliplatin Injection Industry Drivers Table 178. Oxaliplatin Injection Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oxaliplatin Injection Product Image Figure 5. Global Oxaliplatin Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oxaliplatin Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Oxaliplatin Injection Sales (2021-2032) & (K Units) Figure 8. Global Oxaliplatin Injection Average Price (US$/Unit) & (2021-2032) Figure 9. Mannitol Product Image Figure 10. Glucose Solution Product Image Figure 11. Lactose Solution Product Image Figure 12. Other Product Image Figure 13. Colorectal Cancer Product Image Figure 14. Ovarian Cancer Product Image Figure 15. Stomach Cancer Product Image Figure 16. Other Product Image Figure 17. Global Oxaliplatin Injection Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Oxaliplatin Injection, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Oxaliplatin Injection Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Oxaliplatin Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Oxaliplatin Injection Sales by Region in 2025 Figure 23. Global Oxaliplatin Injection Revenue by Region in 2025 Figure 24. North America Oxaliplatin Injection Market Size by Country in 2025 Figure 25. North America Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 26. North America Oxaliplatin Injection Revenue Market Share by Country (2021-2032) Figure 27. United States Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Oxaliplatin Injection Market Size by Country in 2025 Figure 30. Europe Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 31. Europe Oxaliplatin Injection Revenue Market Share by Country (2021-2032) Figure 32. Germany Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific Oxaliplatin Injection Market Size by Country in 2025 Figure 38. Asia Pacific Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific Oxaliplatin Injection Revenue Market Share by Country (2021-2032) Figure 40. China Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America Oxaliplatin Injection Market Size by Country in 2025 Figure 49. South America Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 50. South America Oxaliplatin Injection Revenue Market Share by Country (2021-2032) Figure 51. Mexico Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa Oxaliplatin Injection Market Size by Country in 2025 Figure 55. Middle East and Africa Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa Oxaliplatin Injection Revenue Market Share by Country (2021-2032) Figure 57. Turkey Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE Oxaliplatin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global Oxaliplatin Injection Sales Market Share by Type (2021-2032) Figure 61. Global Oxaliplatin Injection Revenue Market Share by Type (2021-2032) Figure 62. Global Oxaliplatin Injection Price (US$/Unit) by Type (2021-2032) Figure 63. Global Oxaliplatin Injection Sales Market Share by Application (2021-2032) Figure 64. Global Oxaliplatin Injection Revenue Market Share by Application (2021-2032) Figure 65. Global Oxaliplatin Injection Price (US$/Unit) by Application (2021-2032) Figure 66. Oxaliplatin Injection Value Chain Figure 67. Oxaliplatin Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Oxaliplatin Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • Mannitol
  • Glucose Solution
  • Lactose Solution
  • Other
Applications
  • Colorectal Cancer
  • Ovarian Cancer
  • Stomach Cancer
  • Other
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Qilu Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Mylan
  • Luoxin
  • Jiangsu Hengrui Medicine
  • Hainan Jinrui Pharmaceutical
  • Fresenius Kabi
  • YRPG
  • Yakult honsha
  • Sanofi-Aventis
  • Lunan Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Jari Pharmaceutical
  • Hospira(Pfizer)
  • Hisun Pharmaceutical
  • Halfsky Pharmacy
  • Dr Reddy's laboratories
  • Chiatai Tianqing

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oxaliplatin Injection Market Size (2021-2032)
  4. 2.2.2 Global Oxaliplatin Injection Sales (2021-2032)
  5. 2.2.3 Global Oxaliplatin Injection Market Average Price (2021-2032)
  6. 2.3 Oxaliplatin Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Mannitol
  9. 2.3.3 Glucose Solution
  10. 2.3.4 Lactose Solution
  11. 2.3.5 Other
  12. 2.4 Oxaliplatin Injection by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Colorectal Cancer
  15. 2.4.3 Ovarian Cancer
  16. 2.4.4 Stomach Cancer
  17. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oxaliplatin Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oxaliplatin Injection Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Oxaliplatin Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oxaliplatin Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oxaliplatin Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oxaliplatin Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oxaliplatin Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Oxaliplatin Injection, Established Date
  9. 3.9 Global Oxaliplatin Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva
  2. 4.1.1 Teva Company Information
  3. 4.1.2 Teva Business Overview
  4. 4.1.3 Teva Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Oxaliplatin Injection Product Portfolio
  6. 4.1.5 Teva Recent Developments
  7. 4.2 Sun Pharmaceutical
  8. 4.2.1 Sun Pharmaceutical Company Information
  9. 4.2.2 Sun Pharmaceutical Business Overview
  10. 4.2.3 Sun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sun Pharmaceutical Oxaliplatin Injection Product Portfolio
  12. 4.2.5 Sun Pharmaceutical Recent Developments
  13. 4.3 Qilu Pharmaceutical
  14. 4.3.1 Qilu Pharmaceutical Company Information
  15. 4.3.2 Qilu Pharmaceutical Business Overview
  16. 4.3.3 Qilu Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Qilu Pharmaceutical Oxaliplatin Injection Product Portfolio
  18. 4.3.5 Qilu Pharmaceutical Recent Developments
  19. 4.4 Nanjing Pharmaceutical Factory
  20. 4.4.1 Nanjing Pharmaceutical Factory Company Information
  21. 4.4.2 Nanjing Pharmaceutical Factory Business Overview
  22. 4.4.3 Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Nanjing Pharmaceutical Factory Oxaliplatin Injection Product Portfolio
  24. 4.4.5 Nanjing Pharmaceutical Factory Recent Developments
  25. 4.5 Mylan
  26. 4.5.1 Mylan Company Information
  27. 4.5.2 Mylan Business Overview
  28. 4.5.3 Mylan Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Mylan Oxaliplatin Injection Product Portfolio
  30. 4.5.5 Mylan Recent Developments
  31. 4.6 Luoxin
  32. 4.6.1 Luoxin Company Information
  33. 4.6.2 Luoxin Business Overview
  34. 4.6.3 Luoxin Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Luoxin Oxaliplatin Injection Product Portfolio
  36. 4.6.5 Luoxin Recent Developments
  37. 4.7 Jiangsu Hengrui Medicine
  38. 4.7.1 Jiangsu Hengrui Medicine Company Information
  39. 4.7.2 Jiangsu Hengrui Medicine Business Overview
  40. 4.7.3 Jiangsu Hengrui Medicine Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jiangsu Hengrui Medicine Oxaliplatin Injection Product Portfolio
  42. 4.7.5 Jiangsu Hengrui Medicine Recent Developments
  43. 4.8 Hainan Jinrui Pharmaceutical
  44. 4.8.1 Hainan Jinrui Pharmaceutical Company Information
  45. 4.8.2 Hainan Jinrui Pharmaceutical Business Overview
  46. 4.8.3 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Product Portfolio
  48. 4.8.5 Hainan Jinrui Pharmaceutical Recent Developments
  49. 4.9 Fresenius Kabi
  50. 4.9.1 Fresenius Kabi Company Information
  51. 4.9.2 Fresenius Kabi Business Overview
  52. 4.9.3 Fresenius Kabi Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Fresenius Kabi Oxaliplatin Injection Product Portfolio
  54. 4.9.5 Fresenius Kabi Recent Developments
  55. 4.10 YRPG
  56. 4.10.1 YRPG Company Information
  57. 4.10.2 YRPG Business Overview
  58. 4.10.3 YRPG Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 YRPG Oxaliplatin Injection Product Portfolio
  60. 4.10.5 YRPG Recent Developments
  61. 4.11 Yakult honsha
  62. 4.11.1 Yakult honsha Company Information
  63. 4.11.2 Yakult honsha Business Overview
  64. 4.11.3 Yakult honsha Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Yakult honsha Oxaliplatin Injection Product Portfolio
  66. 4.11.5 Yakult honsha Recent Developments
  67. 4.12 Sanofi-Aventis
  68. 4.12.1 Sanofi-Aventis Company Information
  69. 4.12.2 Sanofi-Aventis Business Overview
  70. 4.12.3 Sanofi-Aventis Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sanofi-Aventis Oxaliplatin Injection Product Portfolio
  72. 4.12.5 Sanofi-Aventis Recent Developments
  73. 4.13 Lunan Pharmaceutical
  74. 4.13.1 Lunan Pharmaceutical Company Information
  75. 4.13.2 Lunan Pharmaceutical Business Overview
  76. 4.13.3 Lunan Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Lunan Pharmaceutical Oxaliplatin Injection Product Portfolio
  78. 4.13.5 Lunan Pharmaceutical Recent Developments
  79. 4.14 Jiangsu Aosaikang Pharmaceutical
  80. 4.14.1 Jiangsu Aosaikang Pharmaceutical Company Information
  81. 4.14.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  82. 4.14.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Product Portfolio
  84. 4.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  85. 4.15 Jari Pharmaceutical
  86. 4.15.1 Jari Pharmaceutical Company Information
  87. 4.15.2 Jari Pharmaceutical Business Overview
  88. 4.15.3 Jari Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Jari Pharmaceutical Oxaliplatin Injection Product Portfolio
  90. 4.15.5 Jari Pharmaceutical Recent Developments
  91. 4.16 Hospira(Pfizer)
  92. 4.16.1 Hospira(Pfizer) Company Information
  93. 4.16.2 Hospira(Pfizer) Business Overview
  94. 4.16.3 Hospira(Pfizer) Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Hospira(Pfizer) Oxaliplatin Injection Product Portfolio
  96. 4.16.5 Hospira(Pfizer) Recent Developments
  97. 4.17 Hisun Pharmaceutical
  98. 4.17.1 Hisun Pharmaceutical Company Information
  99. 4.17.2 Hisun Pharmaceutical Business Overview
  100. 4.17.3 Hisun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hisun Pharmaceutical Oxaliplatin Injection Product Portfolio
  102. 4.17.5 Hisun Pharmaceutical Recent Developments
  103. 4.18 Halfsky Pharmacy
  104. 4.18.1 Halfsky Pharmacy Company Information
  105. 4.18.2 Halfsky Pharmacy Business Overview
  106. 4.18.3 Halfsky Pharmacy Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Halfsky Pharmacy Oxaliplatin Injection Product Portfolio
  108. 4.18.5 Halfsky Pharmacy Recent Developments
  109. 4.19 Dr Reddy's laboratories
  110. 4.19.1 Dr Reddy's laboratories Company Information
  111. 4.19.2 Dr Reddy's laboratories Business Overview
  112. 4.19.3 Dr Reddy's laboratories Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Dr Reddy's laboratories Oxaliplatin Injection Product Portfolio
  114. 4.19.5 Dr Reddy's laboratories Recent Developments
  115. 4.20 Chiatai Tianqing
  116. 4.20.1 Chiatai Tianqing Company Information
  117. 4.20.2 Chiatai Tianqing Business Overview
  118. 4.20.3 Chiatai Tianqing Oxaliplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Chiatai Tianqing Oxaliplatin Injection Product Portfolio
  120. 4.20.5 Chiatai Tianqing Recent Developments
5 Global Oxaliplatin Injection Market Scenario by Region
  1. 5.1 Global Oxaliplatin Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oxaliplatin Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Oxaliplatin Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Oxaliplatin Injection Sales by Region: 2027-2032
  5. 5.3 Global Oxaliplatin Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Oxaliplatin Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Oxaliplatin Injection Revenue by Region: 2027-2032
  8. 5.4 North America Oxaliplatin Injection Market Facts & Figures by Country
  9. 5.4.1 North America Oxaliplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oxaliplatin Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Oxaliplatin Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Oxaliplatin Injection Market Facts & Figures by Country
  15. 5.5.1 Europe Oxaliplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Oxaliplatin Injection Sales by Country (2021-2032)
  17. 5.5.3 Europe Oxaliplatin Injection Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Oxaliplatin Injection Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Oxaliplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Oxaliplatin Injection Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Oxaliplatin Injection Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Oxaliplatin Injection Market Facts & Figures by Country
  35. 5.7.1 South America Oxaliplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Oxaliplatin Injection Sales by Country (2021-2032)
  37. 5.7.3 South America Oxaliplatin Injection Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Oxaliplatin Injection Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Oxaliplatin Injection Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Oxaliplatin Injection Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Oxaliplatin Injection Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Oxaliplatin Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Oxaliplatin Injection Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Oxaliplatin Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oxaliplatin Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Oxaliplatin Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oxaliplatin Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oxaliplatin Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oxaliplatin Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Oxaliplatin Injection Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Oxaliplatin Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oxaliplatin Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Oxaliplatin Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oxaliplatin Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oxaliplatin Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oxaliplatin Injection Value Chain Analysis
  2. 8.1.1 Oxaliplatin Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oxaliplatin Injection Production Mode & Process
  5. 8.2 Oxaliplatin Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oxaliplatin Injection Distributors
  8. 8.2.3 Oxaliplatin Injection Customers
9 Global Oxaliplatin Injection Analyzing Market Dynamics
  1. 9.1 Oxaliplatin Injection Industry Trends
  2. 9.2 Oxaliplatin Injection Industry Drivers
  3. 9.3 Oxaliplatin Injection Industry Opportunities and Challenges
  4. 9.4 Oxaliplatin Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst